Navigation Links
STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%
Date:1/15/2008

a further significant increase in R&D expenses.

2008 outlook

The Group gives guidance of double-digit sales growth. 2008 results should be impacted by additional R&D investments in the US.

The questions asked by the German agency regarding the ORALAIR(R) Grasses file have been dealt with and we expect a licence to be issued.

Talks are continuing with potential partners in the US.

About STALLERGENES

Stallergenes is a European biopharmaceutical company dedicated to desensitization treatments for the prevention and cure of allergy-related respiratory diseases, e.g. rhino-conjunctivitis, rhinitis and allergic asthma.

A pioneer and leader in sublingual desensitization treatments, Stallergenes devotes 18% of its sales to Research and Development and is today fully involved in the development of a new therapeutic family, the sublingual desensitization tablets.

StallergEnes realised 2007 sales of EUR 147 million, of which half outside France.

StallergEnes' shares are listed on Compartment B of the Euronext Paris Stock Exchange.

ISIN code: FR0000065674, Reuters code: GEN.PA, Bloomberg code: GEN.FP

For additional information on StallergEnes, please visit our website: http://www.stallergenes.com


'/>"/>
SOURCE Stallergenes
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
2. Volcano Announces Activities at TCT 2007: Expanded Role of IVUS in PCI to be Demonstrated
3. CleveMed Receives $1.5 Million in NIH Funding to Further Develop a Portable System for Monitoring Parkinsons Disease Motor Symptoms
4. SAFC Hitech(TM) Plans Further Expansion Into Asia
5. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
6. Agencourt Genomic Services is Key Collaborator in New Research That Further Defines Landscape of Breast and Colon Cancers
7. Organons Asenapine Further Demonstrates Efficacy in Reducing Mania Symptoms for the Treatment of Bipolar I Disorder
8. New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrines Anti-PS Technology Platform
9. Monitorforhire.com Adds Mobile Phone Capability Further Speeding Access to Experienced Monitors
10. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
11. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , The Scientist, a leadi... ranked Photometrics’ Evolve “Intellig...on’s “Top 10 Innovations of 2009. , ... The Evolve ™ EMCCD camera from Photometr...formance CCD and EMCCD cameras for the life scienc...
(Date:12/1/2009)... , Dr. Kerry Solomon anno...ns and has launched his redesigned website at www...al Consulting Group. Dr. Solomon is a proven LASI...as been professionally recognized for his substant...urgery. He is a member of Trusted LASIK Surgeons,...
(Date:12/1/2009)... , , NEW YORK, Dec. 1 /PRNewswire/ ...search report is available in its catalogue: ,,.../www.reportlinker.com/p0164494/Chromium---Global-M...mium is primarily influenced by stainless steel, w...e markets is also important for growth of chromium...
(Date:12/1/2009)... , , NEW YORK, Dec. 1 /PRNewswire/ ...search report is available in its catalogue: ,,...pe: Market dynamics and the changing healthcare an...linker.com/p0165658/Emerging-Clinical-Trial-Locati...ing-healthcare-and-regulatory-environment.html ,...
Breaking Biology Technology:The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8
...daq: VICL ) presentation at the UBS Global Life S....m. Eastern Daylight Time, will be available by,li... http://www.vical.com ., About Vical, Vical res...sed on its,patented DNA delivery technologies for ...reatening diseases. Potential applications of the,...
...gnificant partial onset seizure reduction, pro... - Keppra XR(TM) is built on a trusted heritage, ...mation:,UCB announced today that the U.S. Food and...TM) (levetiracetam extended-release tablets) for u...for people with partial-onset,seizures who are 16 ...
...n Deficit Hyperactivity ...nual ,ADHD Experts on,Call, program will take plac... midnight EDT to provide families and caregivers o...sorder (ADHD), as well as adults with,ADHD, with t...ut ADHD from,experts in the field. Celebrity desig...
Other Biology Technology:Vical to Present at UBS Global Life Sciences Conference 2Video: Keppra XR(TM) Approved in the U.S. 2Video: Keppra XR(TM) Approved in the U.S. 3Video: Keppra XR(TM) Approved in the U.S. 4Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 2Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 3Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 4Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 5Celebrity Designer Ty Pennington to Host 10th Annual 'ADHD Experts on Call' Program 6
(Date:12/2/2009)... about a nanometer in diameterhave been highly tou... fibers, electrical wires in molecular devices, or...s to a new development by researchers at the Natio...nd five partners, you can add one more application...essive form of breast cancer. , HER2 is one of a...
(Date:12/2/2009)...y of Southampton,s School of Ocean and Earth Scien...thampton (NOCS) has formally described four new sp...l discovered the new species in the Smithsonian Co...y in Washington. Explaining the significance of th...largest crustaceans currently inhabiting Earth and...
(Date:12/1/2009)...esearch Center, Emory University, have successfull... important step toward unlocking the genetic secre...s technology will enable scientists to perform a h...fy the brain mechanisms of social bonding and othe...lso have important implications for understanding ...
Breaking Biology News(10 mins):Combining nanotubes and antibodies for breast cancer 'search and destroy' missions 2King crab family bigger than ever 2Yerkes researchers create first transgenic prairie voles 2Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 1Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 2Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 3Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 4Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 5Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 6Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 7Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 8Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 9Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 10Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 11Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 12Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 13Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate 28TM 29 Topical Gel for Non Healing Diabetic Foot Ulcers and Plans for Phase 3 59445 14Webcast Alert 3A Usinas Siderurgicas de Minas Gerais S A USIMINAS Announces Third Quarter 2009 Results Webcast 59442 1Webcast Alert 3A Usinas Siderurgicas de Minas Gerais S A USIMINAS Announces Third Quarter 2009 Results Webcast 59442 2Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 1Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 2Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 3Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 4Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 5Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 6Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 7Cardium Announces Commercial Development of Excellagen 28TM 29 a Customized Collagen Based Topical Gel for Initial Use as an Adjunct to Surgical Debri 59439 8
...searchers have long suspected that fertilizer runo... marine algae capable of disrupting ocean ecosyste... a new study by Stanford University scientists pre...e coastal farming to massive algal blooms in the s...l Nature, the authors conclude that some highly pr...
... one time, scientists wondered whether life existe... kinds of creatures, they wondered, could withstan...nvironment? , Researchers at Scripps Institution ...an Diego, and their colleagues have used innovatio...urate portrayal of deep sea life forms and how the...
...e simple marine sponge is inspiring cutting-edge r...ersity of California, Santa Barbara. , A report a...of gold nanoparticles is the cover story of the cu...terials. The article is written by Daniel E. Morse...al biology at UCSB, and director of the Institute ...
Other Biology News:Oceans more vulnerable to agricultural runoff than previously thought, study finds 2Oceans more vulnerable to agricultural runoff than previously thought, study finds 3Oceans more vulnerable to agricultural runoff than previously thought, study finds 4Advancements In Genomics Foster Deep Sea Discoveries 2Marine sponge yields nanoscale secrets 2Marine sponge yields nanoscale secrets 3
GC-RICH PCR System from Roche Applied Science
GC-RICH PCR System from Roche Applied Science
BD Laminin 60 mm Culture Dishes from BD Biosciences - Discovery Labware
BD BioCoat Collagen I 60 mm Culture Dishes from BD Biosciences - Discovery Labware
Biology Products: